DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
CTS-1027
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Unknown
CTS-1027
×
Maximum Phase:
2
First Approval:
None
UNII:
2QD3F58224
Molecule Type:
Small molecule
Molecular Formula:
C19H20ClNO6S
Molecular Weight:
425.89
AlogP:
3.21
PSA:
101.93
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TAK-448
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Hypogonadism
Unknown
TAK-448
×
Maximum Phase:
2
First Approval:
None
UNII:
YO029HR229
Molecule Type:
Small molecule
Molecular Formula:
C58H80N16O14
Molecular Weight:
1225.38
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PRS-211375
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Cannabinoid CB2 receptor agonist
PRS-211375
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOCIPARSTAT SODIUM
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOCIPARSTAT SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
4O75889WF4
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
9-AMINOCAMPTOTHECIN
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Esophageal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Lymphoma; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms
Unknown
9-AMINOCAMPTOTHECIN
×
Maximum Phase:
2
First Approval:
None
UNII:
5MB77ICE2Q
Molecule Type:
Small molecule
Molecular Formula:
C20H17N3O4
Molecular Weight:
363.37
AlogP:
1.66
PSA:
107.44
HBD:
2.0
HBA:
#RotB:
1.0
Source:
SOTB07
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SOTB07
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VESTIPITANT MESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Neurokinin 1 receptor antagonist
VESTIPITANT MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
OWR424W90Q
Molecule Type:
Small molecule
Molecular Formula:
C24H28F7N3O4S
Molecular Weight:
587.56
AlogP:
5.93
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BATEFENTEROL
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
BATEFENTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
1IAT42T80T
Molecule Type:
Small molecule
Molecular Formula:
C40H42ClN5O7
Molecular Weight:
740.26
AlogP:
6.43
PSA:
165.25
HBD:
6.0
HBA:
#RotB:
13.0
Source:
GW-274150
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Arthritis, Rheumatoid; Migraine Disorders
Nitric oxide synthase, inducible inhibitor
GW-274150
×
Maximum Phase:
2
First Approval:
None
UNII:
0ZZF1V8G63
Molecule Type:
Small molecule
Molecular Formula:
C8H17N3O2S
Molecular Weight:
219.31
AlogP:
0.11
PSA:
99.2
HBD:
4.0
HBA:
#RotB:
7.0
Source:
IBUDILAST
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies; Glioblastoma; Migraine Disorders; Pain; Substance-Related Disorders; Alcoholism; Amphetamine-Related Disorders; Amyotrophic Lateral Sclerosis; Multiple Sclerosis, Chronic Progressive; Opioid-Related Disorders; Pneumonia, Viral; Lung Diseases, Obstructive; Spinal Cord Diseases
Phosphodiesterase 10A inhibitor
IBUDILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
M0TTH61XC5
Molecule Type:
Small molecule
Molecular Formula:
C14H18N2O
Molecular Weight:
230.31
AlogP:
3.3
PSA:
34.37
HBD:
0.0
HBA:
#RotB:
3.0
Source:
BATABULIN
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
BATABULIN
×
Maximum Phase:
2
First Approval:
None
UNII:
T4NP8G3K6Q
Molecule Type:
Small molecule
Molecular Formula:
C13H7F6NO3S
Molecular Weight:
371.26
AlogP:
3.33
PSA:
55.4
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IBEZAPOLSTAT
2
Small molecule
Investigational
Unknown
Unknown
Clostridium Infections
Unknown
IBEZAPOLSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
5K543KNC5P
Molecule Type:
Small molecule
Molecular Formula:
C18H20Cl2N6O2
Molecular Weight:
423.3
AlogP:
2.37
PSA:
88.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
VRC-01LS
2
Unknown
Investigational
Unknown
Unknown
HIV Infections
T-cell surface antigen CD4 binding agent
VRC-01LS
×
Maximum Phase:
2
First Approval:
None
UNII:
6JM4WD2J1A
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NS-2359
2
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Depressive Disorder
Monoamine transporter inhibitor
NS-2359
×
Maximum Phase:
2
First Approval:
None
UNII:
76H76554PA
Molecule Type:
Small molecule
Molecular Formula:
C16H21Cl2NO
Molecular Weight:
314.26
AlogP:
4.21
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
F18-FFNP
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
F18-FFNP
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUBENTYLOSIN
2
Small molecule
Investigational
Unknown
Unknown
Onchocerciasis
Unknown
FLUBENTYLOSIN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C53H82FNO17
Molecular Weight:
1024.23
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
L-NAME
2
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Asthma
Unknown
L-NAME
×
Maximum Phase:
2
First Approval:
None
UNII:
V55S2QJN2X
Molecule Type:
Small molecule
Molecular Formula:
C7H15N5O4
Molecular Weight:
233.23
AlogP:
-1.43
PSA:
143.37
HBD:
4.0
HBA:
#RotB:
6.0
Source:
CC-115
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Squamous Cell; Glioblastoma; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Metastasis; Osteosarcoma; Prostatic Neoplasms, Castration-Resistant
DNA-dependent protein kinase inhibitor
CC-115
×
Maximum Phase:
2
First Approval:
None
UNII:
FII75TFH5L
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PBF-680
2
Small molecule
Investigational
Unknown
Unknown
Asthma
Adenosine A1 receptor antagonist
PBF-680
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CJM-112
2
Unknown
Investigational
Unknown
Unknown
Multiple Myeloma; Psoriasis; Acne Vulgaris; Asthma; Hidradenitis Suppurativa
Interleukin 17A binding agent
CJM-112
×
Maximum Phase:
2
First Approval:
None
UNII:
F7B2Y24NOE
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALAGEBRIUM
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure, Diastolic
Unknown
ALAGEBRIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
DGH49JXB1F
Molecule Type:
Small molecule
Molecular Formula:
C13H14NOS+
Molecular Weight:
232.33
AlogP:
2.54
PSA:
20.95
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PAGOCLONE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
GABA-A receptor; anion channel positive allosteric modulator
PAGOCLONE
×
Maximum Phase:
2
First Approval:
None
UNII:
38VAG2SA33
Molecule Type:
Small molecule
Molecular Formula:
C23H22ClN3O2
Molecular Weight:
407.9
AlogP:
5.38
PSA:
63.16
HBD:
0.0
HBA:
#RotB:
6.0
Source:
RADALBUVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
RADALBUVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
273K4V0SPC
Molecule Type:
Small molecule
Molecular Formula:
C30H41NO6S
Molecular Weight:
543.73
AlogP:
5.4
PSA:
96.3
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LIVOLETIDE
2
Protein
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Prader-Willi Syndrome
Unknown
LIVOLETIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
9VHD7J6363
Molecule Type:
Protein
Molecular Formula:
C40H63N15O13
Molecular Weight:
962.04
AlogP:
-6.34
PSA:
458.3
HBD:
15.0
HBA:
#RotB:
17.0
Source:
HPC, CORD BLOOD
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HPC, CORD BLOOD
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VIS-410
2
Unknown
Investigational
Unknown
Unknown
Influenza, Human
Hemagglutinin inhibitor
VIS-410
×
Maximum Phase:
2
First Approval:
None
UNII:
14WE3Z92C4
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDUSATUMAB VEDOTIN
2
Antibody
Investigational
Unknown
Unknown
Neoplasms; Stomach Neoplasms
Heat-stable enterotoxin receptor binding agent
INDUSATUMAB VEDOTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
3F0FR4W3H8
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SOTRASTAURIN
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Lymphoma, Large B-Cell, Diffuse; Colitis, Ulcerative; Psoriasis; Uveitis, Posterior
Protein kinase C (PKC) inhibitor
SOTRASTAURIN
×
Maximum Phase:
2
First Approval:
None
UNII:
7I279E1NZ8
Molecule Type:
Small molecule
Molecular Formula:
C25H22N6O2
Molecular Weight:
438.49
AlogP:
2.43
PSA:
94.22
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TALACOTUZUMAB
2
Antibody
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
Interleukin-3 receptor subunit alpha binding agent
TALACOTUZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
X8JR0I7JE1
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
11C-CARFENTANIL
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
11C-CARFENTANIL
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
STG-001
2
Small molecule
Investigational
Unknown
Unknown
Stargardt Disease
Unknown
STG-001
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C14H10F6N2O2
Molecular Weight:
352.23
AlogP:
4.06
PSA:
55.12
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ELX-02
2
Unknown
Investigational
Unknown
Unknown
Genetic Diseases, Inborn; Kidney Diseases; Cystic Fibrosis; Cystinosis
80S Ribosome modulator
ELX-02
×
Maximum Phase:
2
First Approval:
None
UNII:
TP732M43NA
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHF-6001
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
Phosphodiesterase 4 inhibitor
CHF-6001
×
Maximum Phase:
2
First Approval:
None
UNII:
0984EU6E2F
Molecule Type:
Small molecule
Molecular Formula:
C30H30Cl2F2N2O8S
Molecular Weight:
687.54
AlogP:
6.32
PSA:
127.1
HBD:
1.0
HBA:
#RotB:
15.0
Source:
TAS-117
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase AKT negative allosteric modulator
TAS-117
×
Maximum Phase:
2
First Approval:
None
UNII:
QI52W1ZIIB
Molecule Type:
Small molecule
Molecular Formula:
C26H24N4O2
Molecular Weight:
424.5
AlogP:
4.33
PSA:
86.19
HBD:
2.0
HBA:
#RotB:
3.0
Source:
REFAMETINIB
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Biliary Tract Neoplasms; Carcinoma, Hepatocellular
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
REFAMETINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
JPX07AFM0N
Molecule Type:
Small molecule
Molecular Formula:
C19H20F3IN2O5S
Molecular Weight:
572.34
AlogP:
3.48
PSA:
107.89
HBD:
4.0
HBA:
#RotB:
9.0
Source:
1
2
…
154
155
156
157
158
159
160
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA